ReviewThe Journal of antibiotics2026
Biosynthesis and enzymology of azaindane natural products.
Review in The Journal of antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
As a representative example of biosynthetic genome mining aimed at identifying biosynthetic gene clusters whose target is unknown core enzymes for known natural products, we review the biosynthesis of altemicidin (1), SB-203207 (2), and SB-203208 (3). Self-resistance gene-guided genome mining led to the identification of the responsible biosynthetic gene cluster, and heterologous expression of the cluster successfully confirmed the production of compounds 1-3. Biochemical analyses and single-gene expression studies demonstrated that the PLP-dependent enzyme SbzP is a core enzyme of this gene cluster. SbzP accepts β-NAD and SAM as substrates to generate the azaindane scaffold common to compounds 1-3. Subsequent in vitro assays revealed the downstream tailoring reactions, involving the α-ketoglutarate-dependent dioxygenase SbzQ, GNAT-type acyltransferase SbzI, ADP-ribose transferases SbzNHO, F420-dependent reductase SbzF, SAM-dependent methyltransferase SbzE, acyl-tRNA-dependent transferase SbzA, and GNAT-type acyltransferase SbzC, which collectively modify the SbzP product to yield the final structure of compound 3. Structural studies of SbzP and SbzI elucidated the molecular basis for substrate recognition and protein-protein interactions. This review highlights the novelty and utility of investigating biosynthetic gene clusters categorized as Group III and provides new insights into the biosynthesis of β-NAD-derived natural products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.